SK Bioscience Co. on Wednesday reported its second-quarter net loss of 11.4 billion won (US$8.3 million), remaining in the red compared with a year ago. The company said in a regulatory filing that it continued to post an operating loss of 19.9 billion won for the April-June period, compared with a loss of 35.3 billion won a year earlier. Revenue rose 1.1 percent to 26.8 billion won. Source: Yonhap News Agency
Bus Services Resume Normal Operations After Floodwaters Recede
October 2, 2026